Little by little.
Pfizer-BioNTech has submitted its clinical trial data to the FDA for emergency use authorization of its dose-reduced (10 μg versus 30 μg in older age groups) COVID-19 vaccine for those ages 5-11 years. | Pfizer 2021
Search This Blog
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
- Get link
- Other Apps
Comments
Post a Comment